We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Off-Label Stent Use May Be Restricted In Wake of FDA Meeting
Off-Label Stent Use May Be Restricted In Wake of FDA Meeting
December 15, 2006
After examining risks related to the off-label use of drug-eluting stents, an FDA panel has recommended the agency consider mandating labeling changes.